Free Trial

The Pennant Group (PNTG) Competitors

The Pennant Group logo
$23.64 -0.27 (-1.13%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$23.64 0.00 (0.00%)
As of 10/17/2025 04:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PNTG vs. PRVA, HTFL, VCYT, CON, SGRY, GRAL, ADUS, ARDT, LFST, and CELC

Should you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Privia Health Group (PRVA), Heartflow (HTFL), Veracyte (VCYT), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), GRAIL (GRAL), Addus HomeCare (ADUS), Ardent Health (ARDT), LifeStance Health Group (LFST), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

The Pennant Group vs. Its Competitors

Privia Health Group (NASDAQ:PRVA) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

In the previous week, The Pennant Group had 4 more articles in the media than Privia Health Group. MarketBeat recorded 5 mentions for The Pennant Group and 1 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.58 beat The Pennant Group's score of -0.18 indicating that Privia Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Privia Health Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
The Pennant Group
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

The Pennant Group has lower revenue, but higher earnings than Privia Health Group. The Pennant Group is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Privia Health Group$1.74B1.80$14.39M$0.11232.09
The Pennant Group$695.24M1.18$22.56M$0.7830.31

Privia Health Group has a beta of 0.83, indicating that its share price is 17% less volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500.

The Pennant Group has a net margin of 3.36% compared to Privia Health Group's net margin of 0.78%. The Pennant Group's return on equity of 9.85% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Privia Health Group0.78% 2.13% 1.25%
The Pennant Group 3.36%9.85%4.04%

Privia Health Group presently has a consensus target price of $28.91, indicating a potential upside of 13.24%. The Pennant Group has a consensus target price of $34.40, indicating a potential upside of 45.52%. Given The Pennant Group's higher possible upside, analysts plainly believe The Pennant Group is more favorable than Privia Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71
The Pennant Group
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 10.7% of Privia Health Group shares are owned by insiders. Comparatively, 5.4% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Privia Health Group and The Pennant Group tied by winning 8 of the 16 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PNTG vs. The Competition

MetricThe Pennant GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$826.38M$4.24B$6.10B$10.50B
Dividend YieldN/A1.25%5.73%4.81%
P/E Ratio30.3130.1684.5227.09
Price / Sales1.18287.67611.79219.27
Price / Cash25.9328.2037.1661.22
Price / Book2.604.7712.246.52
Net Income$22.56M$197.51M$3.32B$276.75M
7 Day Performance-2.92%4.86%1.25%2.00%
1 Month Performance-4.52%5.00%6.28%2.26%
1 Year Performance-32.17%28.02%59.92%35.58%

The Pennant Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PNTG
The Pennant Group
3.7408 of 5 stars
$23.64
-1.1%
$34.40
+45.5%
-32.8%$826.38M$695.24M30.317,000Analyst Forecast
Short Interest ↑
PRVA
Privia Health Group
2.9221 of 5 stars
$24.14
+0.2%
$28.91
+19.8%
+38.4%$2.96B$1.74B219.471,140
HTFL
Heartflow
N/A$33.22
-0.7%
$36.60
+10.2%
N/A$2.79BN/A0.00699
VCYT
Veracyte
3.8884 of 5 stars
$34.09
-2.0%
$40.90
+20.0%
+4.4%$2.74B$445.76M103.31790News Coverage
CON
Concentra Group Holdings Parent
2.5159 of 5 stars
$20.17
-0.7%
$27.75
+37.6%
-5.8%$2.60B$1.90B16.9511,250
SGRY
Surgery Partners
3.6222 of 5 stars
$19.79
+0.3%
$31.14
+57.4%
-37.7%$2.53B$3.11B-13.8415,000
GRAL
GRAIL
0.5814 of 5 stars
$70.44
+6.5%
$56.67
-19.6%
+449.3%$2.38B$125.60M-5.371,360Trending News
Insider Trade
ADUS
Addus HomeCare
4.8085 of 5 stars
$112.58
-0.3%
$137.50
+22.1%
-11.1%$2.08B$1.15B24.8549,703Positive News
ARDT
Ardent Health
3.6678 of 5 stars
$14.10
+0.4%
$19.30
+36.9%
-24.8%$2.01B$5.97B7.7924,900News Coverage
Analyst Forecast
LFST
LifeStance Health Group
3.3701 of 5 stars
$5.11
+1.2%
$8.50
+66.3%
-30.1%$1.96B$1.25B-102.2010,218News Coverage
CELC
Celcuity
2.5324 of 5 stars
$47.41
+2.9%
$56.50
+19.2%
+236.3%$1.95BN/A-13.7440News Coverage
Analyst Upgrade
Gap Down

Related Companies and Tools


This page (NASDAQ:PNTG) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners